Vanishing white matter disease with different faces.
Brugada syndrome
EIF2B gene
Epilepsy
MRI
Vanishing white matter (VWM)
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
15
06
2019
accepted:
28
07
2019
pubmed:
7
8
2019
medline:
22
6
2021
entrez:
7
8
2019
Statut:
ppublish
Résumé
The goal of this study was to better understand vanishing white matter (VWM) disease, which is one of the most common hereditary white matter disorders, and its relationship to radiologic features, genetic analyses, and clinical findings. We performed a study on 11 patients to describe the clinical and neuroimaging features of VWM. Patients were grouped into "infantile," "early childhood," and "juvenile" based on their onset age. EIF2B1-5 genes encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B) were analyzed in all patients with clinically suspected VWM disease. In brain magnetic resonance imaging (MRI), all patients showed white matter abnormalities with various degrees. The initial clinical presentation in five of patients was ataxia, with severe refractory epilepsy in three patients. In children with infantile-onset VWM, a rapid deterioration of motor function was detected, and the frequency of epilepsy was higher. Two patients showed manifestations of end-stage VWM disease, and one of them had chronic subdural hematoma. One of our patients and his father were diagnosed with Brugada syndrome. Sequencing of the exons and exon-intron boundaries of the EIF2B1-5 genes revealed mutations in the genes EIF2B5 (5 cases), EIF2B3 (3 cases), and EIF2B4 (2 cases). We also found a novel mutation in one patient: c.323_325delGAA in the EIF2B1 gene. In this study, in addition to classical clinical and radiological findings, we wanted to emphasize that we may be confronted with refractory epilepsy (early infancy), cardiac problems, and intracranial complications that may occur in advanced stages.
Identifiants
pubmed: 31385086
doi: 10.1007/s00381-019-04334-6
pii: 10.1007/s00381-019-04334-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
353-361Références
J Neuropathol Exp Neurol. 2010 Oct;69(10):987-96
pubmed: 20838246
J Neurol. 2018 Jun;265(6):1410-1418
pubmed: 29663120
Eur J Pediatr. 2009 Apr;168(4):477-85
pubmed: 18551314
PLoS One. 2015 Mar 11;10(3):e0118001
pubmed: 25761052
J Cent Nerv Syst Dis. 2014 Jul 13;6:59-68
pubmed: 25089094
Neurology. 1997 Apr;48(4):845-55
pubmed: 9109866
J Magn Reson Imaging. 2012 Apr;35(4):926-32
pubmed: 22128017
J Paediatr Child Health. 2005 Jan-Feb;41(1-2):65-7
pubmed: 15670229
Radiology. 1999 Nov;213(2):400-6
pubmed: 10551219
Eur Radiol. 2005 Nov;15(11):2284-303
pubmed: 16021451
Neurology. 2009 Feb 24;72(8):750-9
pubmed: 19237705
Neurology. 2002 Dec 24;59(12):1966-8
pubmed: 12499492
Brain. 2009 Aug;132(Pt 8):2161-9
pubmed: 19625339
Ment Retard Dev Disabil Res Rev. 2006;12(2):123-8
pubmed: 16807905
Neuropediatrics. 2012 Feb;43(1):22-6
pubmed: 22430157
J Neuropathol Exp Neurol. 2004 Jun;63(6):618-30
pubmed: 15217090
Ann Neurol. 2002 Oct;52(4):506-10
pubmed: 12325082
J Neuroophthalmol. 2018 Mar;38(1):42-46
pubmed: 28902089
Neurology. 1995 Aug;45(8):1526-32
pubmed: 7644053
Arch Neurol. 2012 Jun;69(6):723-7
pubmed: 22312162
Am J Hum Genet. 2003 Nov;73(5):1199-207
pubmed: 14566705
Lancet Neurol. 2006 May;5(5):413-23
pubmed: 16632312
J Child Neurol. 2008 Feb;23(2):205-15
pubmed: 18263758
Neurol Sci. 2006 Sep;27(4):271-7
pubmed: 16998732
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Eur J Paediatr Neurol. 2017 Mar;21(2):410-413
pubmed: 27665184
Neurology. 2004 May 11;62(9):1509-17
pubmed: 15136673
Circulation. 2000 Nov 14;102(20):2509-15
pubmed: 11076825
Eur Cardiol. 2019 Apr;14(1):45-49
pubmed: 31131036